Skip to main content
Caplight Logo









Ubie

Ubie

Private
New York City, New YorkHealthcare & Life Scienceshttps://ubiehealth.com/

Last Round

Series C

Extension

Jun 26, 2025

Total Funding Raised

$248.4M

Company Overview

Ubie is a health-tech company that develops an AI-powered platform to guide patients from symptoms to appropriate medical care and improve operational efficiency for healthcare providers.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Patient Engagement, Vertical SaaS, Healthcare Analytics, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Freemium

AI Layer

Application

Keywords

AI symptom checkermedical AIpatient intakepatient discoveryAI doctorclinical triagehealthcare provider SaaSpharma marketingclinical workflowdigital healthpatient engagementvertical SaaSrare disease marketing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ubie Comparables

Compare Ubie with similar companies based on industry and business-model similarity.

Ubie comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fabric (US)
81%
Mediktor
79%
Infermedica
79%

Ubie Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionJun 26, 2025
DebtMay 8, 2025
StrategicOct 8, 2024
Corporate FundingApr 12, 2024
DebtApr 12, 2024
Series C Extension
Dec 8, 2022

Key People

Founding team and executive leadership

Kota Kubo

Co-Founder CEO, Ubie U.S.

Founding Team

Shoko Suzuki

CEO And Director Of Singapore

Executive Team

Yuku Kotani

CTO

Executive Team

Ubie Investors

Notable investors and investment history

Ubie investors
InvestorRounds
Japan Post CapitalStrategic
Sumitomo Mitsui Trust BankDebt, Corporate Funding
Shinsei Capital PartnersSeries C
株式会社日本政策金融公庫Debt, Strategic, Series C Extension
D4V (Design for Ventures)Seed, Series A
MUFG BankDebt
Rakuten CapitalSeries C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Launched a new LLM-based chat platform for patient health guidance.

  • Feb 12, 2026

    Developing AI platform with Mayo Clinic for patient navigation.

Ubie Filings

Explore SEC and related filing metadata, where available.

Ubie filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ubie's valuation, stock price, and market status.

Is Ubie a public or private company?

Ubie is a private company.

What is the current stock price of Ubie?

Ubie is a private company with no public stock price. No recent secondary market data is available.

How much is Ubie worth (valuation)?

Valuation information for Ubie is not publicly available.

Can I buy Ubie stock?

Ubie shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ubie's last funding round?

Ubie's most recent funding round was Series C Extension on June 26, 2025.

Who are the main investors in Ubie?

Key investors in Ubie include Shinsei Capital Partners, 株式会社日本政策金融公庫, Rakuten Capital, Norinchukin Capital, NVenture Capital Co., Ltd..

Will Ubie IPO soon?

No public IPO plans have been announced for Ubie.

How can I track Ubie secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ubie's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range250
Year Founded2017
Last FundingJun 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?